Aktieanalys

Annexin: Positive top-line readout in phase IIa RVO trial - Redeye

{newsItem.title}

Redeye Publicerad: 21 Aug 13:01

Redeye gives an initial take on the positive phase IIa results in RVO with ANXV, an imporant milestone for the company.

Länk till analysen i sin helhet: https://www.redeye.se/research/1032078/annexin-positive-top-line-readout-in-phase-iia-rvo-trial?utm_source=finwire&utm_medium=RSS

Nyheter om Annexin

Läses av andra just nu

Om aktien Annexin

Senaste nytt